• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冠状动脉钙化的遗传风险评分及其对冠状动脉疾病的预测能力。

Genetic risk score for coronary artery calcification and its predictive ability for coronary artery disease.

作者信息

Mishra Pashupati P, Mishra Binisha H, Lyytikäinen Leo-Pekka, Goebeler Sirkka, Martiskainen Mika, Hakamaa Emma, Kleber Marcus E, Delgado Graciela E, März Winfried, Kähönen Mika, Karhunen Pekka J, Lehtimäki Terho

机构信息

Department of Clinical Chemistry, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.

Finnish Cardiovascular Research Center Tampere, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.

出版信息

Am J Prev Cardiol. 2024 Oct 10;20:100884. doi: 10.1016/j.ajpc.2024.100884. eCollection 2024 Dec.

DOI:10.1016/j.ajpc.2024.100884
PMID:39483246
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11525111/
Abstract

AIM

The modest added predictive value of the existing genetic risk scores (GRSs) for coronary artery disease (CAD) could be partly due to missing genetic components, hidden in the genetic architecture of intermediate phenotypes such as coronary artery calcification (CAC). In this study, we investigated the predictive ability of CAC GRS for CAD.

MATERIALS AND METHODS

We investigated the association of CAC GRSs with CAD and coronary calcification among the participants in the Ludwigshafen Risk and Cardiovascular Health study (LURIC) ( = 2742), the Tampere Vascular Study (TVS) ( = 133), and the Tampere Sudden Death Study (TSDS) ( = 660) using summary data from the largest multi-ancestry GWAS meta-analysis of CAC to date. Added predictive value of the CAC GRS over the traditional CVD risk factors as well as metaGRS, a GRS for CAD constructed with 1.7 million genetic variants, was tested with standard train-test machine learning approach using the LURIC data, which had the largest sample size.

RESULTS

CAC GRS was significantly associated with CAD in LURIC (OR=1.41, 95 % CI [1.28-1.55]), TVS (OR=1.79, 95 % CI [1.05-3.21]) as well as in TSDS (OR=4.20, 95 % CI [1.74-10.52]). CAC GRS showed strong association with calcification areas in left (OR=1.78, 95 % CI [1.16-2.74]) and right (OR=1.71, 95 % CI [1.98-2.67]) coronary arteries. There was statistically significant added predictive value of the CAC GRS for CAD over the used traditional CVD risk factors (AUC 0.734 vs 0.717, p-value = 0.02). Furthermore, CAC GRS improved the prediction accuracy for CAD when combined with metaGRS.

CONCLUSIONS

This study showed that CAC GRS is a new risk marker for CAD in three European cohorts, with added predictive value over the traditional CVD risk factors.

摘要

目的

现有冠状动脉疾病(CAD)遗传风险评分(GRS)的预测价值有限,部分原因可能是遗漏了隐藏在诸如冠状动脉钙化(CAC)等中间表型遗传结构中的遗传成分。在本研究中,我们调查了CAC GRS对CAD的预测能力。

材料与方法

我们利用迄今为止最大规模的多血统GWAS对CAC的荟萃分析的汇总数据,在路德维希港风险与心血管健康研究(LURIC)(n = 2742)、坦佩雷血管研究(TVS)(n = 133)和坦佩雷猝死研究(TSDS)(n = 660)的参与者中,研究了CAC GRS与CAD和冠状动脉钙化之间的关联。使用样本量最大的LURIC数据,采用标准的训练-测试机器学习方法,测试了CAC GRS相对于传统心血管疾病风险因素以及metaGRS(一种由170万个遗传变异构建的CAD GRS)的额外预测价值。

结果

在LURIC(OR = 1.41,95%CI[1.28 - 1.55])、TVS(OR = 1.79,95%CI[1.05 - 3.21])以及TSDS(OR = 4.20,95%CI[1.74 - 10.52])中,CAC GRS与CAD显著相关。CAC GRS与左冠状动脉(OR = 1.78,95%CI[1.16 - 2.74])和右冠状动脉(OR = 1.71,95%CI[1.98 - 2.67])的钙化面积显示出强烈关联。与所使用的传统心血管疾病风险因素相比,CAC GRS对CAD具有统计学上显著的额外预测价值(AUC 0.734对0.717,p值 = 0.02)。此外,当与metaGRS结合时,CAC GRS提高了CAD的预测准确性。

结论

本研究表明,CAC GRS是三个欧洲队列中CAD的一种新的风险标志物,相对于传统心血管疾病风险因素具有额外的预测价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7eca/11525111/3ccc2e7d1fd8/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7eca/11525111/ecefed7fc7d6/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7eca/11525111/0b8cbd812356/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7eca/11525111/3a1cb85229e2/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7eca/11525111/3ccc2e7d1fd8/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7eca/11525111/ecefed7fc7d6/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7eca/11525111/0b8cbd812356/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7eca/11525111/3a1cb85229e2/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7eca/11525111/3ccc2e7d1fd8/gr3.jpg

相似文献

1
Genetic risk score for coronary artery calcification and its predictive ability for coronary artery disease.冠状动脉钙化的遗传风险评分及其对冠状动脉疾病的预测能力。
Am J Prev Cardiol. 2024 Oct 10;20:100884. doi: 10.1016/j.ajpc.2024.100884. eCollection 2024 Dec.
2
Using a genetic risk score to calculate the optimal age for an individual to undergo coronary artery calcium screening.利用遗传风险评分计算个体进行冠状动脉钙化筛查的最佳年龄。
J Cardiovasc Comput Tomogr. 2019 Jul-Aug;13(4):203-210. doi: 10.1016/j.jcct.2019.05.005. Epub 2019 May 9.
3
The role of coronary artery calcification testing in incident coronary artery disease risk prediction in type 1 diabetes.冠状动脉钙化检测在 1 型糖尿病患者新发冠状动脉疾病风险预测中的作用。
Diabetologia. 2019 Feb;62(2):259-268. doi: 10.1007/s00125-018-4764-2. Epub 2018 Nov 14.
4
Relationship between genomic risk scores (GRS) and coronary artery calcium (CAC) score: A pilot study.基因组风险评分(GRS)与冠状动脉钙(CAC)评分的关系:一项初步研究。
Clin Nutr ESPEN. 2022 Feb;47:293-298. doi: 10.1016/j.clnesp.2021.11.029. Epub 2021 Nov 27.
5
Pharmacogenetic association of diabetes-associated genetic risk score with rapid progression of coronary artery calcification following treatment with HMG-CoA-reductase inhibitors -results of the Heinz Nixdorf Recall Study.基于他汀类药物治疗的冠状动脉钙化进展的糖尿病相关遗传风险评分的药物遗传学相关性-海因茨·尼克斯多夫回顾性研究的结果。
Naunyn Schmiedebergs Arch Pharmacol. 2021 Aug;394(8):1713-1725. doi: 10.1007/s00210-021-02100-7. Epub 2021 May 22.
6
A genetic risk score is associated with incident cardiovascular disease and coronary artery calcium: the Framingham Heart Study.遗传风险评分与心血管疾病和冠状动脉钙化的发生相关:弗雷明汉心脏研究。
Circ Cardiovasc Genet. 2012 Feb 1;5(1):113-21. doi: 10.1161/CIRCGENETICS.111.961342. Epub 2012 Jan 10.
7
Genetic risk scores for coronary artery disease and its traditional risk factors: Their role in the progression of coronary artery calcification-Results of the Heinz Nixdorf Recall study.用于冠心病及其传统危险因素的遗传风险评分:它们在冠状动脉钙化进展中的作用——Heinz Nixdorf 回顾研究的结果。
PLoS One. 2020 May 7;15(5):e0232735. doi: 10.1371/journal.pone.0232735. eCollection 2020.
8
Prediction of Coronary Artery Disease and Major Adverse Cardiovascular Events Using Clinical and Genetic Risk Scores for Cardiovascular Risk Factors.利用心血管危险因素的临床和遗传风险评分预测冠心病和主要不良心血管事件。
Circ Genom Precis Med. 2022 Oct;15(5):e003441. doi: 10.1161/CIRCGEN.121.003441. Epub 2022 Jul 13.
9
Predictive improvement of adding coronary calcium score and a genetic risk score to a traditional risk model for cardiovascular event prediction.预测性改善:在传统心血管事件预测风险模型中加入冠状动脉钙评分和遗传风险评分。
Eur J Prev Cardiol. 2024 Apr 18;31(6):709-715. doi: 10.1093/eurjpc/zwae005.
10
Targeted Coronary Artery Calcium Screening in High-Risk Younger Individuals Using Consumer Genetic Screening Results.基于消费级基因筛查结果对高危年轻个体进行靶向冠状动脉钙筛查。
JACC Cardiovasc Imaging. 2021 Jul;14(7):1398-1406. doi: 10.1016/j.jcmg.2020.11.013. Epub 2021 Jan 13.

引用本文的文献

1
A non-invasive prediction model for coronary artery stenosis severity based on multimodal data.基于多模态数据的冠状动脉狭窄严重程度无创预测模型。
Front Physiol. 2025 Jun 2;16:1592593. doi: 10.3389/fphys.2025.1592593. eCollection 2025.

本文引用的文献

1
Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification.多民族全基因组研究鉴定出冠状动脉钙化的效应基因和可用药途径。
Nat Genet. 2023 Oct;55(10):1651-1664. doi: 10.1038/s41588-023-01518-4. Epub 2023 Sep 28.
2
Assessment of plasma ceramides as predictor for subclinical atherosclerosis.评估血浆神经酰胺作为亚临床动脉粥样硬化预测指标的作用。
Atheroscler Plus. 2021 Oct 2;45:25-31. doi: 10.1016/j.athplu.2021.09.005. eCollection 2021 Nov.
3
Polygenic risk scores for the prediction of cardiometabolic disease.
用于预测心血管代谢疾病的多基因风险评分。
Eur Heart J. 2023 Jan 7;44(2):89-99. doi: 10.1093/eurheartj/ehac648.
4
Cost-Effectiveness of Polygenic Risk Scores to Guide Statin Therapy for Cardiovascular Disease Prevention.多基因风险评分指导他汀类药物治疗心血管疾病预防的成本效益。
Circ Genom Precis Med. 2022 Oct;15(5):e003423. doi: 10.1161/CIRCGEN.121.003423. Epub 2022 Jul 29.
5
Impact of polygenic risk communication: an observational mobile application-based coronary artery disease study.多基因风险沟通的影响:一项基于移动应用程序的冠状动脉疾病观察性研究。
NPJ Digit Med. 2022 Mar 11;5(1):30. doi: 10.1038/s41746-022-00578-w.
6
Clinical utility of polygenic risk scores for coronary artery disease.用于冠心病的多基因风险评分的临床实用性。
Nat Rev Cardiol. 2022 May;19(5):291-301. doi: 10.1038/s41569-021-00638-w. Epub 2021 Nov 22.
7
Genetic risk scores for coronary artery disease and its traditional risk factors: Their role in the progression of coronary artery calcification-Results of the Heinz Nixdorf Recall study.用于冠心病及其传统危险因素的遗传风险评分:它们在冠状动脉钙化进展中的作用——Heinz Nixdorf 回顾研究的结果。
PLoS One. 2020 May 7;15(5):e0232735. doi: 10.1371/journal.pone.0232735. eCollection 2020.
8
Polygenic Hyperlipidemias and Coronary Artery Disease Risk.多基因高脂血症与冠状动脉疾病风险。
Circ Genom Precis Med. 2020 Apr;13(2):e002725. doi: 10.1161/CIRCGEN.119.002725. Epub 2020 Mar 10.
9
Predictive Accuracy of a Polygenic Risk Score-Enhanced Prediction Model vs a Clinical Risk Score for Coronary Artery Disease.多基因风险评分增强预测模型与临床风险评分对冠状动脉疾病预测的准确性比较。
JAMA. 2020 Feb 18;323(7):636-645. doi: 10.1001/jama.2019.22241.
10
Using a genetic risk score to calculate the optimal age for an individual to undergo coronary artery calcium screening.利用遗传风险评分计算个体进行冠状动脉钙化筛查的最佳年龄。
J Cardiovasc Comput Tomogr. 2019 Jul-Aug;13(4):203-210. doi: 10.1016/j.jcct.2019.05.005. Epub 2019 May 9.